期刊
MOVEMENT DISORDERS
卷 25, 期 10, 页码 1464-1469出版社
WILEY-BLACKWELL
DOI: 10.1002/mds.23114
关键词
cohort studies; Parkinson's disease/parkinsonism; ultrasound
资金
- Universities of Homburg, Innsbruck, and Tuebingen
- BMBF [01GS0116, 01GS08134]
- Janssen Pharmaceuticals
- TEVA Pharma GmbH
- German Parkinson's disease Association
- Dr. Werner Jackstadt Foundation
- German Research Foundation
- Robert and Clarice Smith Fellowship in Neurodegenerative Disease and Stroke Award
- American Neurological Association
- Movement disorders Society
- Mayo Clinic
- Michael J. Fox Foundation
- Robert Bosch Foundation
- Novartis
- Helmholtz association
- Hertie Foundation
- Eisai
- Teva
- GSK
- Boehringer-Ingelheim
- UCB
- Orion Pharma
- Merck Serono
- Schering plough
Enlarged substantia nigra hyperechogenicity (SN+) assessed by transcranial sonography (TCS) may be associated with Parkinson's disease (PD) risk markers such as impaired motor performance and hyposmia. The aim of this multicenter cross-sectional study was to define the association between SN+ and these risk markers in a large population older than 50 years without the diagnosis of PD. In three centers (Tuebingen, Homburg, and Innsbruck), 1,839 individuals were examined. The echostatus of the SN was assessed by TCS, motor performance by the Unified Parkinson's Disease Rating Scale (UPDRS) motor score, and olfactory function with Sniffin' Sticks. From the 1,603 subjects included in the analysis, 16.2% were SN+, 23.0% scored above zero in the UPDRS motor section, and 28.0% were hyposmic as defined by less than 75% correctly classified Sniffin' Sticks. SN+ was associated with a UPDRS motor score above zero (OR 1.45, 95% CI 1.08-1.96) and with a lower odor identification capability (OR 1.48, 95% Cl 1.12-1.96). The combination of these two features (OR 1.98, 95% Cl 1.25-3.15) and UPDRS motor scores >= 3 lead to higher OR. It is concluded that SN+, impaired motor performance, and hyposmia are frequently observed in the elderly and in isolation are unspecific and of limited use to predict a subject's risk for PD. Whether the association of SN+ with both impaired motor performance and hyposmia as seen in this study predicts an increased risk for the development of PD needs to be evaluated in the follow-up investigations. (C) 2010 Movement Disorder Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据